S. Kanno

Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies

Emma McCullagh, D. T. Hung, S. Bernales, 2017, The Journal of Pharmacology and Experimental Therapeutics.

Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies

Emma McCullagh, S. Bernales, L. Delgado, 2017, The Journal of Pharmacology and Experimental Therapeutics.

JPET # 238022 1 Dual Inhibition of Bruton ’ s Tyrosine Kinase and Phosphoinositide-3-Kinase p 110 δ as a Therapeutic Approach to Treat Non-Hodgkin ’ s B cell Malignancies

Emma McCullagh, L. Delgado, R. Rai, 2017 .

Discovery of Pyrazolopyrimidine Derivatives as Novel Dual Inhibitors of BTK and PI3Kδ.

Emma McCullagh, S. Bernales, Anamika Thakur, 2016, ACS medicinal chemistry letters.